Impact of biologic therapies on need for hip and knee replacement among rheumatoid arthritis and non-rheumatoid arthritis patients in Ontario, Canada: An interrupted time-series analysis
Rates of orthopaedic surgery among rheumatoid arthritis (RA) patients have been decreasing in several developed countries. One explanatory factor could be the introduction of biologic therapies. Whilst we recently tested this hypothesis using UK data, analyses that account for concurrent trends in n...
Main Authors: | Hawley, S, Ling, V, Edwards, C, Arden, N, Cooper, C, Judge, A, Paterson, M, Hawker, G, Prieto-Alhambra, D |
---|---|
Format: | Conference item |
Published: |
Oxford University Press
2017
|
Similar Items
-
Descriptive epidemiology of hip and knee replacement in rheumatoid arthritis: an analysis of UK electronic medical records
by: Hawley, S, et al.
Published: (2019) -
The Impact of Biologic Therapy Introduction on Hip and Knee Replacement Among Rheumatoid Arthritis Patients: An Interrupted Time Series Analysis Using the Clinical Practice Research Datalink
by: Hawley, S, et al.
Published: (2016) -
Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: an interrupted time-series analysis
by: Hawley, S, et al.
Published: (2017) -
Incidence of knee and hip replacements in rheumatoid arthritis patients following introduction of biological dmards: an interrupted time series analysis using nationwide health care registers
by: Cordtz, R, et al.
Published: (2017) -
Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers
by: Cordtz, R, et al.
Published: (2017)